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CASE REPORT

A Fatal Rectus Sheath Hematoma After a Myasthenia Crisis:
A Case Report
Robert G. Michaud, MD, MPH,1 Lesley B. Gordon, MD, MS1,2
1

Tufts University School of Medicine, Boston, MA, 2 Maine Medical Partners Hospital Medicine, Portland, ME

Introduction:

Rectus sheath hematomas (RSH) are generally caused by damage to the inferior epigastric artery.
They are rare causes of abdominal pain or acute anemia due to blood loss, but they are an important
diagnostic consideration because they can be cryptic and potentially fatal.

Clinical Findings: An 85-year-old female who was admitted to the hospital for 10 days with a myasthenia crisis was
abruptly hypotensive with a tender abdominal mass in the left lower quadrant that subtly crossed the
midline. She was on prophylactic anticoagulation during her hospitalization.
Diagnosis,
Interventions,
and Outcomes:

The patient was initially stabilized with fluids and given one unit of packed red blood cells. Results from a
computed tomography angiography of her abdomen and pelvis showed a type III RSH. She underwent
a percutaneous embolization of her inferior epigastric artery via interventional radiology. Unfortunately,
she did not recover and was transitioned to hospice, where she died 1 day after discharge.

Conclusion:

Classic teaching associates RSHs with systemic anticoagulation and a physical exam notable for a
mass not crossing the midline. However, a wider range of presentations, including an abdominal mass
that crosses the midline, can occur. Other important risk factors include frailty, immunosuppression, and
possibly abdominal injections (particularly heparin).
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CASE PRESENTATION
An 85-year-old female, whose medical history
noted a recent diagnosis of myasthenia gravis,
was transferred to our tertiary care hospital in
a myasthenia crisis with increasing generalized
weakness and respiratory failure. Her home
medications included prednisone, but no
antiplatelet or anticoagulant medications. Due to
her declining respiratory status, she was intubated
on hospital day 2. She was given 5 doses of
intravenous immunoglobulin (20 g per dose) and
methylprednisolone (1 g per dose). She remained
on prophylactic anticoagulation throughout her
hospitalization. She received subcutaneous
abdominal injections of enoxaparin 40 mg daily at
the outside hospital and then was transitioned to
heparin 5000 units every 12 hours at our institution.
Correspondence: Robert G. Michaud, MD, MPH
Maine Medical Center
2 Bramhall St. Portland, ME 04102
rmichaud@mmc.org
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She received no other abdominal injections. She
was extubated on hospital day 6, transitioned to
prednisone 40 mg daily, and transferred to the
general medicine unit. She was medically stable
and being prepared for discharge to a skilled
nursing facility.
On hospital day 11, she developed severe
abdominal pain in her left lower quadrant. She
was hypotensive to 80/50 mmHg (prior range: 140170/60-80 mmHg), her extremities were cool, and
she was somnolent. She had a new 3.5-cm firm,
tender mass in her left lower quadrant that subtly
crossed the midline. She was temporarily stabilized
with 2 L lactated ringers and 1 unit packed red
blood cells. Her hemoglobin dropped from 11.7 g/dL
to 9.7 g/dL. Given our concern for intra-abdominal
pathology, she underwent a computed tomography
angiography of her abdomen and pelvis. The scan
revealed a large hematoma that originated in the
left rectus sheath, with active extravasation from
the inferior epigastric artery, and expansion into
1
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the extraperitoneal space within the pelvis (Figure
1). Interventional radiology successfully embolized
the inferior epigastric artery, but the patient had
persistent hypotension after resuscitation and
continued to decline. She developed ischemic
hepatitis and acute renal failure. Given her
continued decrease in consciousness and prior
goals of care, she was transitioned to comfort
measures and discharged to hospice. She died 1
day after discharge.

or percutaneous interventions.3,4 Type II and III
RSHs may cross the midline, involving both rectus
muscles, and typically resolve within 3 months.3,4,6
The average RSH volume or estimated blood
loss varies widely. One study found that the mean
volume ranged from 612.5 mL (SD = 225 mL) to
940 mL (SD = 371.5 mL). Another study found that
it ranged from 687 ± 614 mL among conservatively
managed patients to 2353 ± 1657 mL among
patients who underwent embolization.8,9

DISCUSSION

A review of 126 cases at a single medical center
identified the top 5 presenting signs and symptoms
of RSH, which included abdominal pain (84%),
abdominal wall mass (63%), a decrease in
hemoglobin by 0.4 g/dL or more (55%), abdominal
wall ecchymosis (17%), and nausea or vomiting
(15%).2 Factors associated with RSHs included
advanced age, systemic anticoagulation, chronic
kidney disease (stage 3 or greater), steroid or
immunosuppressant treatment, trauma, and
abdominal injections. More recent cases also
found abdominal wall straining (e.g., coughing) as
a factor.1,2,4 RSHs are two to three times more likely
to occur in females than in males.1,2,4

A rare cause of abdominal pain is a rectus sheath
hematoma (RSH), which accounts for approximately
1.8% of cases.1-4 A RSH is a collection of blood
within the aponeurosis of the rectus abdominis
muscle that is due to damage to the epigastric
artery or the rectus muscle.3,4 The rectus abdominis
muscles are separated by the linea alba, accounting
for the unilateral nature of most RSHs. They are
surrounded by the aponeuroses of the internal
oblique, transversus abdominis, and external
oblique muscles, which together form the rectus
sheath.4,5 The inferior epigastric artery is particularly
vulnerable to injury because it runs along the
posterior surface of the rectus abdominis muscle
and then penetrates the rectus sheath at the arcuate
line. This line is where the rectus sheath transitions
from surrounding the rectus abdominis muscle to
only running along the anterior surface (Figure
2).6 Although RSHs can occur above the arcuate
line, they are generally less severe and self-limited
because the surrounding sheath tamponades the
hematoma and prevents its expansion.7 Thus, most
RSHs occur in the lower abdominal quadrants and
are often more severe.6,7
There are 3 types of RSHs (Figure 3). Type I
hematomas are mild, intramuscular, and unilateral
hemorrhages that do not lead to hemodynamic
instability. These hematomas can be managed
conservatively and generally resolve within 30
days.3,4 Type II hematomas are larger, and the
hemorrhage extends between the transversalis
fascia and rectus abdominis. This hematoma
can lead to a decreased hematocrit and may
require bed rest, hemodynamic assistance, and
analgesia. Type III hematomas, the most severe,
are hemorrhages that extend to the peritoneum and
perivascular space.3,4 These hematomas generally
require further hemodynamic assistance with blood
transfusions and are more likely to need surgery
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Figure 1. Computed tomography angiography of
abdomen and pelvis. The scan revealed a type
III rectus sheath hematoma that expanded into
the extraperitoneal space within the pelvis. Arrow,
contrast extravasation from the inferior epigastric
artery.
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Figure 2. Axial illustration of the abdominal muscles surrounding the arcuate line. The abdominal muscles
(A) above and (B) below the arcuate line at which the rectus sheath transitions from surrounding the
rectus abdominis muscle to only covering the anterior portion.
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A – Type I RSH

B – Type II RSH

C – Type III RSH
Figure 3. Illustration of the 3 types of rectus sheath hematomas in the axial view. A, Type I hematoma is
within the rectus abdominis muscle. B, Type II hematoma extends outside the muscle and dissects the
surrounding fascial layers. C, Type III hematoma extravasates to the peritoneum and perivascular space.
RSH, rectus sheath hematoma.
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Our patient was not given therapeutic
anticoagulation. She was female, elderly, and given
prophylactic heparin injections in her abdomen
and pulse therapy doses of corticosteroids
(defined as ≥ 250mg of prednisone-equivalent
per day). These factors likely increased her risk
for developing a RSH.10 Although RSHs tend to
present as a unilateral mass, they can cross the
midline, as demonstrated by this case. With the
increasing prevalence of systemic anticoagulation,
the occurrence of RSHs may increase.4 RSHs are
rarely fatal (~2-4% overall), but the fatality risk
may increase in patients receiving anticoagulation
treatment.2,4,6,11 Physicians must carefully consider
a RSH in patients who develop a painful abdominal
mass, regardless of midline involvement, to ensure
prompt diagnosis and treatment.
Prior case reports highlighted that RSHs may be
associated with abdominal injections and steroids or
immunosuppressants.1,12-14 Systemic corticosteroids
have been linked with spontaneous bruising and
disrupted wound healing.15 Future studies should
investigate how corticosteroid dose may affect the
development and outcomes of RSHs. Additionally,
the association between abdominal injections and
RSHs should be explored. If abdominal injections
increase the risk of RSHs, this risk could be
mitigated by choosing other locations (eg, thighs
or upper arms) for prophylactic anticoagulation or
insulin injections in the hospital.
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